while marked success has been demonstrated over the years in tumor-bearing animal models , the feasibility of such work in humans has been greatly improved by the experimental expansion and maintenance of immune lymphocytes ( those exposed to antigenic challenge ) in vitro using either highly purified or recombinant , interleukin 2 .
C0086418
humans
C0021756
recombinant